1256585-04-2: Alectinib M4 Metabolite

1256585-04-2: Alectinib M4 Metabolite

Alectinib M4 Metabolite (CAS No: 1256585-04-2) is a major metabolite of Alectinib that is a small-molecule ALK inhibitor used for the treatment of patients with ALK-positive unresectable, recurrent/advanced Non-small cell lung cancer.

Additional information on CAS 1256585-04-2

Catalogue No.

VL5710003
CAS No.

1256585-04-2
Molecular Formula

C₂₈H₃₂N₄O₂
Molecular Weight

456.58 g/mol
Parent drug

Alectinib
IUPAC Name

9-ethyl-8-(4-((2-hydroxyethyl)amino)piperidin-1-yl)-6, 6-dimethyl-11-oxo-6, 11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Synonyms

N/A
References

Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354,  https://doi.org/10.1016/j.heliyon.2017.e00354.
Status

In-stock

Other products related to alectinib

[rfq_list]

Login first to add product to RFQ List

Request a quote

1256585-04-2: Alectinib M4 Metabolite

1256585-04-2: Alectinib M4 Metabolite
Catalogue No.

VL5710003
CAS No.

1256585-04-2
Molecular Formula

C₂₈H₃₂N₄O₂
Molecular Weight

456.58 g/mol
Parent drug

Alectinib
IUPAC Name

9-ethyl-8-(4-((2-hydroxyethyl)amino)piperidin-1-yl)-6, 6-dimethyl-11-oxo-6, 11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Synonyms

N/A
References

Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354,  https://doi.org/10.1016/j.heliyon.2017.e00354.
Status

In-stock
ListName

Alectinib M4 Metabolite
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden